Stemline Targeting cancer at its root
developing novel drugs that attack Cancer Stem Cells


The Company
Stemline Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing novel therapeutics that target both cancer stem cells (CSCs) and tumor bulk.
Clinical Trials
Cancer Stem Cells
Platform
Stemline Therapeutics has developed a Discovery Platform called StemScreen to identify novel compounds that target and kill CSCs.


News
&
Events
4/25/2016
Stemline Announces Oral Presentation of SL-401 Phase 2 BPDCN Data at ASCO 2016
3/14/2016
Stemline Therapeutics Reports Fourth Quarter 2015 Financial Results
3/14/2016
Stemline Therapeutics to Present at the 28th Annual ROTH Conference
Copyright 2016 - Stemline Therapeutics, Inc. All rights reserved
Stemline